发明名称 AMINO-LNA, THIO-LNA AND ALPHA-L-OXY-LN
摘要 A novel class of pharmaceuticals which comprises a Locked Nucleic Acid (LNA) which can be used in antisense therapy. These novel oligonucleotides have improved antisense properties. The novel oligonucleotides are composed of at least one LNA selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA. The oligonucleotides comprising LNA may also include DNA and/or RNA nucleotides.
申请公布号 US2014128586(A1) 申请公布日期 2014.05.08
申请号 US201314073722 申请日期 2013.11.06
申请人 SANTARIS PHARMA A/S 发明人 CHRISTENSEN SIGNE M.;MIKKELSEN NIKOLAJ DAM;FRIEDEN MIRIAM;HANSEN HENRIK FRYDENLUND;KOCH TROELS;PEDERSEN DANIEL SEJER;ROSENBOHM CHRISTOPH;THRUE CHARLOTTE ALBAEK;WESTERGAARD MAJKEN
分类号 C07H19/04;A61K31/7088;C07H21/00;C12N15/11 主分类号 C07H19/04
代理机构 代理人
主权项
地址